NASDAQ:IMNM | Profit Breakdown | Immunome Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$78.14M-$73.13M
2026-03-31$0.00-$59.33M-$53.84M
2025-12-31$0.00-$72.86M-$69.9M
2025-09-30$0.00-$60.14M-$57.46M
2025-06-30$4.02M-$46.48M-$43.4M
2025-03-31$2.93M-$44.64M-$41.64M
2024-12-31$2.74M-$82.97M-$80.25M
2024-09-30$2.91M-$50.52M-$47.1M
2024-06-30$2.36M-$40.01M-$36.12M
2024-03-31$1.03M-$132.3M-$129.49M
2023-12-31$3.83M-$94.65M-$92.63M
2023-09-30$3.57M-$4.63M-$4.35M
2023-06-30$4.26M-$5.77M-$5.56M
2023-03-31$2.36M-$4.47M-$4.27M
2022-12-31-$7.79M-$7.79M
2022-09-30-$8.53M-$8.53M
2022-06-30-$8.93M-$8.92M
2022-03-31-$11.65M-$11.65M
2021-12-31-$7.84M-$7.85M
2021-09-30-$7.72M-$7.72M
2021-06-30-$5.74M-$5.24M
2021-03-31-$3.9M-$3.9M
2020-12-31-$4.07M-$4.07M
2020-09-30-$2.82M-$8.38M
2020-06-30-$2.72M-$2.71M
2020-03-31-$2.66M-$2.68M
2019-12-31-$2.89M-$2.92M
2019-09-30-$2.72M-$2.74M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$6.94M-$224.11M-$212.39M
2024-12-31$9.04M-$305.8M-$292.96M
2023-12-31$14.02M-$109.53M-$106.81M
2022-12-31-$36.9M-$36.9M
2021-12-31-$25.2M-$24.71M
2020-12-31-$12.26M-$17.84M
2019-12-31-$10.35M-$10.44M